BlogBest Practices for M&A Due Diligence: Avoiding Nightmares & Optimizing Value
27 February, 2019The one-hour session explores many of the nightmares often experienced during due diligence and how to avoid them.
Insight on What Matters - So You Can Transform Your Business.
The one-hour session explores many of the nightmares often experienced during due diligence and how to avoid them.
Taking appropriate steps to instill quality control at each point in the process is the first step, but achieving quality across the discovery spectrum requires well-defined processes, solid documentation, strong collaboration capabilities and a means to measure results.
The Promise and Challenges of Antibody-Drug Conjugates (ADC) Antibody-drug conjugates, or ADCs, are a new class of highly potent biopharmaceutical drug that can ferry drugs into cancer cells while...
ShareVault 4.0.1, released today, includes important changes to permissioning and policies, as well as a number of other minor improvements.
Blockchain–Trends & Transactions Blockchain is quickly shaping out to be an established enterprise technology. There are new technologies and capabilities emerging almost daily, as well as new job...
In most M&A transactions, the parties arrive at a purchase price by multiplying the target company’s earnings before interest, taxes, depreciation, and amortization (EBITDA) by an agreed-upon...
Precision medicine is a move away from a one-size-fits-all approach toward an approach with the goal to target the right treatments to the right patients at the right time.
ShareVault CEO Richard Andersen recently sat down with Matt Ferrari, the Chief Technology Officer at ClearDATA to discuss how the cloud can be used to protect, securely manage, and fully automate many healthcare applications, data and IT infrastructure.
Every day, business owners are approached by third parties interested in buying their business. These buyers could be individuals, direct competitors, or private equity groups. Even if you’ve never...
Life Sciences companies don’t move from founding to exit over the course of a year or two; it happens over many years or a decade. That’s typically enough time to get things right, but also affords...